RK

Raj Kumar Srivastava

Director Director DIN 06395529
DIN 06395529 First appointment Dec 2012 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Raj Kumar Srivastava

Data last updated:

Raj Kumar Srivastava was a Director at Astha Pharma Private Limited (2012–2016) and Director at Astha Nutrients & Beverage Limited (from 2012). The companies operate in Pharma.

DIN 06395529
Primary Designation Director
Industry Pharma
First Appointment 07 Dec 2012
Oldest Company Age 13 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Astha Pharma Private Limited U24233MH2012PTC238574
Director07 Dec 20122012Strike Off
Astha Nutrients & Beverage Limited U15549MH2012PLC238774
Director13 Dec 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Astha Nutrients & Beverage Limited
Astha Pharma Private Limited
Premium access

Shareholding and investment profile for Raj Kumar Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raj Kumar Srivastava

Raj Kumar Srivastava was first appointed on 07 Dec 2012 as Director at Astha Pharma Private Limited.

Raj Kumar Srivastava held 2 earlier board appointments: Astha Pharma Private Limited (Director, 07 Dec 2012 to 31 Jan 2016); Astha Nutrients & Beverage Limited (Director, from 13 Dec 2012).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available